2060 POSTER An open-label study of neoadjuvant capecitabine (C) and docetaxel (D) with/without trastuzumab (T) to determine the role of p53 mutations in clinical and pathological responses in patients with recently diagnosed breast cancer (BC)

✍ Scribed by P. Nancy; S. Truong; D. Tripathy; S. Glück; U. Dugan; L. Wu

• Book ID: 118625664
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 60 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70822-4